Natascha Kleiter
7. July 2018 2024-10-08 13:11Natascha Kleiter
Natascha Kleiter,
Section of Translational Cell Genetics,
Medical University InnsbruckTitle: The nuclear orphan receptor NR2F6 as a new cancer immune checkpoint
Section of Translational Cell Genetics,
Medical University InnsbruckTitle: The nuclear orphan receptor NR2F6 as a new cancer immune checkpoint
Natascha Kleiter has characterized NR2F6 as an intracellular immune checkpoint, directly repressing transcription of cytokine genes in T cells relevant for cancer cell rejection and therefore enhancing tumor immune surveillance.
https://phd-school.i-med.ac.at/phd-programs/doctoralprogram/molecular-cell-biology
Related Posts
Ulrich Kalinke
15. June 2023
735 views
Burkhard Ludewig
28. April 2023
866 views
Clemens Schmitt
22. September 2022
795 views
Matthias Ernst
2. June 2022
776 views
Werner Held
22. April 2022
729 views
Search
Categories